Editorial: The EpiPen Outrage Continues

Wednesday, September 21, 2016 - 23:21 in Mathematics & Economics

It’s time for Congress to stop letting pharmaceutical companies get away with price gouging on lifesaving drugs.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net